A new study used CRISPR-Cas9 gene editing to develop bovine muscle cells without alpha-gal, a sugar molecule linked to Alpha-Gal Syndrome (AGS), a potentially life-threatening allergy triggered by mammalian meat. The study presents a proof of concept for producing cultivated meat that may be safer for people affected by the condition.

Aflatoxin contamination caused by Aspergillus flavus threatens the development of peanut industry, breeding aflatoxin-resistant peanut varieties are highly needed. In this study, a recombinant inbred line (RIL) population was developed from a cross between Zhonghua 16 and Kainong H03-3—a high-oleic acid peanut line exhibiting resistance to both A. flavus infection and aflatoxin production. Using this RIL population,

Genome editing has emerged as one of the most transformative biotechnological tools for modern agriculture, which enable precise crop improvement with unprecedented speed and accuracy. However, all currently available plant genome editing systems are derived from naturally occurring bacterial or archaeal proteins. In addition, the two most widely used genome editing platforms, Cas9 and Cas12, are protected by complex intellectual property frameworks, limiting their global accessibility and commercial deployment in some regions.